Biocon Secures U.S. FDA Approval for Liraglutide, Strengthening Its Position in the Booming Weight Loss Market
Biocon Limited has received approval from the U.S. Food and Drug Administration for its weight management drug, Liraglutide, branded…
Biocon Limited has received approval from the U.S. Food and Drug Administration for its weight management drug, Liraglutide, branded…
Novo Nordisk will slash U.S. list prices for its blockbuster drugs Wegovy and Ozempic by up to 50%. The…
Novo Nordisk has moved quickly to steady investor nerves after disappointing trial results for its obesity candidate CagriSema. The…
Eli Lilly and Company has won approval from the U.S. Food and Drug Administration for a new multi-dose version…
Weight-loss drugs could soon face stricter scrutiny in Olympic sport. The growing popularity of medications like Ozempic and Wegovy…
Sesame Care is a U.S.-based direct-to-patient healthcare marketplace designed to simplify how individuals access medical services. Founded with the…
CVS Caremark plays a central role in shaping prescription drug access for millions of Americans. As one of the…
Pharmaceutical companies are racing to transform weight‑loss treatment. They are shifting from weekly injections to daily pills, opening easier…
The rapid rise of GLP-1 receptor agonist medications has fundamentally reshaped the weight-loss industry. Once reserved primarily for type…
Weight loss treatment has changed quickly. Telehealth now makes prescription care easier to access. Ro offers a structured online…